谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 257 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Preliminary Biomarker Analysis in the Phase 3 PIVOTAL Study: Evidence of the Mechanism of Action of Daromun in Melanoma Patients
K. C. Kaehler,P. A. Ascierto,M. Ziemer, J. C. Hassel, P. Rutkowski,F. Meier,L. Flatz,C. Gaudy-Marqueste, M. Santinami,F. Russano,I. von Wasielewski,T. Eigentler, M. Maio,I. Zalaudek,S. Haferkamp, P. Quaglino,C. Garbe, C. Robert, A. Hauschild, D. Schadendorf
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2024): 26-26
引用0浏览0引用
0
0
Efficacy of BRAF/MEK-inhibitor Therapy for Epithelioid Glioblastoma with a Novel BRAFV600 Mutation
J. Steininger, C. Buszello,R. Oertel,M. Meinhardt, S. Schmid,K. Engellandt, S. Herold,S. Stasik, A. Ebrahimi,B. Renner, C. Thiede, I.Y. Eyüpoglu,G. Schackert,S. Beissert,F. Meier, J. Radke,D. Westphal,T. A. Juratli
ACTA NEUROPATHOLOGICA COMMUNICATIONSno. 1 (2024)
引用0浏览0WOS引用
0
0
Treatment of Brain Metastases with T-Cell Receptor-modified T-Cells
M. Garzarolli,R. Rauschenberg, C. M. Britten, K. Epp,K. Wetzko,F. Meier,M. Wermke
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2024): 26-27
引用0浏览0引用
0
0
LBA45 Early Switch from Targeted to Immunotherapy in Advanced BRAFV600-positive Melanoma: Long-term OS and Final PFS Results of the Randomized Phase II ImmunoCobiVem Trial
D. Schadendorf, H. Gogas,L. Kandolf Sekulovic,F. Meier,T.K. Eigentler, M. Ziemer, P. Terheyden,A. Gesierich, R. Herbst,K.C. Kähler,D.C. Ziogas,Ž. Mijušković,M. Garzarolli, C. Garbe, A. Roesch,S. Ugurel-Becker, R. Gutzmer, J.J. Grob, L. Zimmer, E. Livingstone
Annals of Oncology (2024): S1235-S1236
引用0浏览0引用
0
0
1124P Adjuvant Treatment of Patients with Stage III Melanoma: 4-Year Follow-Up Time of Multicenter Real-World Study
E. Livingstone,A. Forschner, J.C. Hassel,I. von Wasielewski,F. Meier, P. Mohr,K.C. Kähler, B. Schilling, M. Erdmann, C. Berking,S. Huning, H. Stege, R. Gutzmer,B. Kowall, A. Stang,W. Galetzka, A. Hauschild, L. Zimmer, D. Schadendorf,G.C. Lodde
Annals of Oncology (2024): S740
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 255

#Citation: 2438

H-Index: 22

G-Index: 49

Sociability: 7

Diversity: 2

Activity: 23

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn